2026-08-11Bullish
-10.46%weekly changeCVS stock fell due to cautious 2027 guidance, H2 profit pull-forwards into Q2, and regulatory concerns surrounding 340B drug rebates.
read the report →CVS Health Corporation is an American multinational healthcare enterprise that provides integrated healthcare solutions through health care benefits, pharmacy benefit management, retail pharmacies, and primary care clinics.
CVS stock fell due to cautious 2027 guidance, H2 profit pull-forwards into Q2, and regulatory concerns surrounding 340B drug rebates.
read the report →